Legacy Bridge’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
VCM
VPM
Legacy Bridge's BMY Position: Q1 2026 in Review
Legacy Bridge sold out of Bristol-Myers Squibb (BMY) in Q1 2026, closing a stake of 295 shares — an estimated $15.9K sold.
Legacy Bridge first reported a position in BMY in Q4 2018 and held it in 21 quarters. The position peaked at $1.71M in Q2 2022. 2,521 funds tracked by Wall St. Rank hold BMY as of Q1 2026.
- Legacy Bridge reported no remaining Bristol-Myers Squibb position as of Q1 2026 after selling out during the quarter.
- Legacy Bridge sold 295 Bristol-Myers Squibb shares in Q1 2026, an estimated $15.9K.
- Legacy Bridge first reported a position in Bristol-Myers Squibb in Q4 2018 and held it in 21 quarters.
- Legacy Bridge's Bristol-Myers Squibb position peaked at $1.71M in Q2 2022.
- 2,521 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.
Based on Legacy Bridge's 13F filing for Q1 2026, filed 14 May 2026.